XML 23 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
Commitments and Contingencies (Tables)
 3 Months Ended
Dec. 31, 2017
Commitments and Contingencies Disclosure [Abstract]  
Schedule of lease payments

The Company is committed to lease payments as follows:

 

Fiscal year ending September 30,        
  2018     $ 86,392  
  2019       57,594  
        $ 143,986  
Schedule of purchase warrants outstanding

A summary of the status of the Company’s outstanding share purchase warrants is presented below:

 

      Number of Shares     Weighted
Average
Exercise
Price		  
Balance, October 1, 2016       1,809,309     $ 2.70  
Exercised        (200,000 )   $ 3.00  
Balance, September 30, 2017 and December 31, 2017       1,609,309     $ 2.66  
Schedule of exercisable share purchase warrants outstanding

At December 31, 2017, the Company had share purchase warrants outstanding of 1,609,309, with a weighted average exercise price of $2.66 as follows:

 

Number     Exercise Price     Expiry Date
                 
  1,262,180     $ 3.00     July 5, 2018
  30,000     $ 4.00     February 24, 2019
  277,127     $ 1.20     March 13, 2019
  1,252     $ 1.68     March 13, 2019
  31,250     $ 1.24     May 31, 2019
  7,500     $ 1.04     May 31, 2019
  1,609,309              
Schedule of outstanding stock purchase options

A summary of the status of Company’s outstanding stock purchase options is presented below:

 

      Number of Shares     Weighted Average Exercise Price     Weighted
Average Grant
Date Fair
Value		  
Outstanding at October 1, 2016       4,199,000     $ 3.76          
Granted       1,107,500       5.51     $ 5.44  
Forfeited       (214,470 )     4.09          
Outstanding at September 30, 2017       5,092,030       4.13          
Granted       545,000       3.30     $ 2.84  
Forfeited       (6,667 )     4.20          
Outstanding at December 31, 2017       5,630,363     $ 4.05          
Exercisable at December 31, 2017       3,526,730     $ 3.28          
Exercisable at September 30, 2017       3,326,223     $ 3.10          
Schedule of stock options outstanding

At December 31, 2017, the following stock options were outstanding:

 

                               
Number of Shares               Aggregate     Remaining  
      Number     Exercise         Intrinsic     Contractual  
Total     Vested     Price     Expiry Date   Value     Life (yrs)  
500,000       500,000     $ 1.60     July 5, 2023   $ 810,000       5.51  
75,000       75,000     $ 1.20     May 7, 2024     151,500       6.35  
125,000       93,750     $ 1.32     May 8, 2024     237,500       6.35  
718,750       718,750     $ 0.92     April 2, 2025     1,653,125       7.25  
29,167       29,167     $ 1.44     June 8, 2025     51,917       7.44  
50,000       33,333     $ 1.76     June 15, 2025     73,000       7.46  
266,250       221,875     $ 5.04     September 18, 2025     —       7.72  
1,500       1,500     $ 5.64     September 30, 2025     —       7.75  
31,250       23,438     $ 5.68     October 2, 2025     —       7.75  
25,000       18,750     $ 8.98     October 16, 2025     —       7.79  
1,500       1,500     $ 5.57     December 31, 2025     —       8.00  
1,500       1,500     $ 4.90     March 31, 2026     —       8.25  
1,500       1,500     $ 5.66     April 27, 2026     —       8.32  
19,697       19,697     $ 4.09     May 18, 2026     —       8.38  
1,500       1,500     $ 6.11     June 30, 2026     —       8.50  
379,625       158,177     $ 6.26     July 5, 2026     —       8.51  
861,429       358,929     $ 7.06     July 18, 2026     —       8.54  
13,333       13,333     $ 3.06     September 7, 2026     2,133       8.68  
1,006,696       1,006,696     $ 3.28     September 22, 2026     —       8.73  
64,166       29,165     $ 3.63     October 3, 2026     —       8.76  
15,000       6,250     $ 4.35     December 9, 2026     —       8.94  
50,000       —     $ 5.39     February 7, 2027     —       9.10  
40,000       13,333     $ 5.26     February 17, 2027     —       9.13  
780,000       195,003     $ 5.92     May 12, 2027     —       9.36  
12,500       2,084     $ 3.42     August 9, 2027     —       9.60  
15,000       2,500     $ 4.33     September 19, 2027     —       9.72  
545,000       —     $ 3.30     December 13, 2027     —       9.95  
5,630,363       3,526,730                 $ 2,979,176          
Schedule of general and administrative expenses and research and development expenses

These amounts have been included in general and administrative expenses and research and development expenses on the Company’s statement of operations as follows:

 

    2017     2016  
General and administrative   $ 571,363     $ 427,583  
Research and development     550,622       461,684  
Total share based compensation   $ 1,121,985     $ 889,267  
Schedule of weighted average assumptions for fair value of each option award

The fair value of each option award is estimated on the date of grant using the Black Scholes option pricing model based on the following weighted average assumptions:

 

    2017     2016  
Risk-free interest rate     2.26 %     1.52 %
Expected life of options (years)     6.60       6.95  
Annualized volatility     112.27 %     111.45 %
Dividend rate     0.00 %     0.00 %